Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alzheimer's disease.

× No keyword cloud information.

321 in total

Review 1. Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors: Benedetta Milanini; Victor Valcour
Journal: Curr HIV/AIDS Rep Date: 2017-08 Impact factor: 5.071

2. Postoperative delirium: a 76-year-old woman with delirium following surgery.

Authors: Edward R Marcantonio
Journal: JAMA Date: 2012-07-04 Impact factor: 56.272

3. Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.

Authors: Annachiara Cagnin; Alberto Cester; Bruno Costa; Mario Ermani; Carlo Gabelli; Giuseppe Gambina
Journal: Neurol Sci Date: 2014-11-14 Impact factor: 3.307

4. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.

Authors: Rashid Deane; Itender Singh; Abhay P Sagare; Robert D Bell; Nathan T Ross; Barbra LaRue; Rachal Love; Sheldon Perry; Nicole Paquette; Richard J Deane; Meenakshisundaram Thiyagarajan; Troy Zarcone; Gunter Fritz; Alan E Friedman; Benjamin L Miller; Berislav V Zlokovic
Journal: J Clin Invest Date: 2012-03-12 Impact factor: 14.808

5. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?

Authors: Agneta Nordberg
Journal: Eur J Nucl Med Mol Imaging Date: 2004-09-15 Impact factor: 9.236

6. Medical imaging in new drug clinical development.

Authors: Yi-Xiang Wang; Min Deng
Journal: J Thorac Dis Date: 2010-12 Impact factor: 2.895

7. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease.

Authors: Magdalena Kulijewicz-Nawrot; Alexei Verkhratsky; Alexander Chvátal; Eva Syková; José J Rodríguez
Journal: J Anat Date: 2012-06-27 Impact factor: 2.610

8. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.

Authors: Michael Gold; Claire Alderton; Marina Zvartau-Hind; Sally Egginton; Ann M Saunders; Michael Irizarry; Suzanne Craft; Gary Landreth; Ulla Linnamägi; Sharon Sawchak
Journal: Dement Geriatr Cogn Disord Date: 2010-08-21 Impact factor: 2.959

Review 9. Diet and Alzheimer's disease.

Authors: José A Luchsinger; James M Noble; Nikolaos Scarmeas
Journal: Curr Neurol Neurosci Rep Date: 2007-09 Impact factor: 5.081

10. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors: Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal: FASEB J Date: 2012-10-24 Impact factor: 5.191